An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee

Trial Profile

An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 26 Dec 2012

At a glance

  • Drugs Tapentadol (Primary)
  • Indications Back pain; Osteoarthritis; Pain
  • Focus Therapeutic Use
  • Sponsors Janssen
  • Most Recent Events

    • 26 Dec 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 07 Sep 2012 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
    • 07 Sep 2012 Actual initiation date (1 Aug 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top